KR900701799A - 결정성(5r, 6s)-2-카바모일옥시메틸-6-[(1r)-하이드록시에틸]-2- 페넴-카복실 산 및 이의 약제형 - Google Patents

결정성(5r, 6s)-2-카바모일옥시메틸-6-[(1r)-하이드록시에틸]-2- 페넴-카복실 산 및 이의 약제형

Info

Publication number
KR900701799A
KR900701799A KR1019900700723A KR900700723A KR900701799A KR 900701799 A KR900701799 A KR 900701799A KR 1019900700723 A KR1019900700723 A KR 1019900700723A KR 900700723 A KR900700723 A KR 900700723A KR 900701799 A KR900701799 A KR 900701799A
Authority
KR
South Korea
Prior art keywords
hydroxyethyl
carbamoyloxymethyl
phenem
carboxylic acid
crystalline form
Prior art date
Application number
KR1019900700723A
Other languages
English (en)
Inventor
바티스티니 카를로
비안치니 로베르토
델 네로 스테파노
그리기 피에르루이기
비오글리오 세르지오
Original Assignee
팜이탈리아 카를로 에르바 에스. 알. 엘.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 팜이탈리아 카를로 에르바 에스. 알. 엘. filed Critical 팜이탈리아 카를로 에르바 에스. 알. 엘.
Publication of KR900701799A publication Critical patent/KR900701799A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

내용 없음

Description

결정성 (5R, 6S )-2-카바모일옥시메틸-6-[(1R) -하이드록시에틸]-2-페넴-카복실 산 및 이의 약제형
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. (5R,6S)-2-카바모일옥시에틸-6-〔(1R)-하이드록시에틸〕-2-페넴-3-카복실 산 분자당 물 분자 2개들 함유하는 상기 산의 절정형.
  2. (a) 나트륨(5R, 6S )-2-카바모일옥시메틸-6-〔(1R)-하이드록시에틸〕 -2-페넴-3-카복실레이트를 함유하는 용액을 산 모는 산성 수지로 처리하고, (b) 임의로 존재하는 불순물질 또는 잔사를 제거한 다음, (C) 상기 페넴 산의 생성된 결정형을 회수함을 특징으로 하여, 제1항에서 정의된 (5R, 6S )-2-카바모일옥시메틸-6-〔(1R)-하이드록시에틸〕-2-페넴-3-카복실 산의 결정형을 제조하는 방법.
  3. 제1항에서 정의된 (5R, 6S)-2-카바모일옥시메틸-6-〔(1R)-하이드록시에틸〕-2-페넴-3-카복실산의 결정형 및 약제학적으로 허용되는 담체 또는 희석제를 함유하는 약제학적 조성물.
  4. 제1항에서 정의된 (5R, 6S )-2-카바모일옥시메틸-6-〔(1R)-하이드록시에틸〕-2-페넴-3-카복실 산의 결정형 및 약염기를 함유하는 약제학적 조성물.
  5. 제4항에 있어서, 약 염기가 아르기닌인 약제학적 조성물.
  6. 제4항에 있어서, 약제학적으로 허용되는 담체 또는 희석제를 추가로 함유하는 약제학적 조성물.
  7. 항균제로 사용하기 위한, 제1항에서 정의된 (5R, 6S)-2-카바모일옥시메틸-6-〔(1R)-하이드록시에틸〕-2-페넴-3-카복실 산의 결정형.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900700723A 1988-08-08 1989-08-04 결정성(5r, 6s)-2-카바모일옥시메틸-6-[(1r)-하이드록시에틸]-2- 페넴-카복실 산 및 이의 약제형 KR900701799A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888818789A GB8818789D0 (en) 1988-08-08 1988-08-08 Crystalline(5r 6s)-2-carbamoyloxymethyl-6-((1r)-hydroxyethyl)-2-penem-carboxylic acid & pharmaceutical formulation
GB8818789.3 1988-08-08
PCT/EP1989/000924 WO1990001484A1 (en) 1988-08-08 1989-08-04 Crystalline (5r,6s)-2-carbamoyloxymethyl-6-[(1r)-hydroxyethyl]-2-penem-carboxylic acid and its pharmaceutical formulation

Publications (1)

Publication Number Publication Date
KR900701799A true KR900701799A (ko) 1990-12-04

Family

ID=10641768

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900700723A KR900701799A (ko) 1988-08-08 1989-08-04 결정성(5r, 6s)-2-카바모일옥시메틸-6-[(1r)-하이드록시에틸]-2- 페넴-카복실 산 및 이의 약제형

Country Status (21)

Country Link
US (1) US5302588A (ko)
EP (1) EP0407478B1 (ko)
JP (1) JP2954956B2 (ko)
KR (1) KR900701799A (ko)
AT (1) ATE112777T1 (ko)
AU (1) AU626576B2 (ko)
CA (1) CA1339422C (ko)
DE (1) DE68918849T2 (ko)
DK (1) DK171235B1 (ko)
ES (1) ES2015770A6 (ko)
FI (1) FI95575C (ko)
GB (1) GB8818789D0 (ko)
GR (1) GR1002251B (ko)
HU (1) HU205934B (ko)
IE (1) IE68447B1 (ko)
IL (1) IL91216A (ko)
NZ (1) NZ230196A (ko)
PT (1) PT91383B (ko)
RU (1) RU2074858C1 (ko)
WO (1) WO1990001484A1 (ko)
ZA (1) ZA895966B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492903A (en) * 1990-06-19 1996-02-20 Takeda Chemical Industries Ltd. Crystalline esters of (+)-(5R, 6S)-6-[(R)-1-hydroxyethyl]-3-(3-pyridyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]he
US20090275746A1 (en) * 2006-07-28 2009-11-05 Hetero Drugs Limited Solid faropenem free acid
KR20160109904A (ko) * 2015-03-13 2016-09-21 주식회사 대웅제약 결정형 도리페넴의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482565A (en) * 1980-02-22 1984-11-13 Farmitalia Carlo Erba S.P.A. β-Lactam-containing antibacterial agents and β-lactamase inhibitors
AT379399B (de) * 1981-12-11 1985-12-27 Erba Farmitalia Verfahren zur herstellung von optisch aktiven penemen
US4761408A (en) * 1984-11-02 1988-08-02 Ciba-Geigy Corporation Crystalline aminomethyl compound
US4634556A (en) * 1985-05-10 1987-01-06 Schering Corporation Crystalline sodium (5R, 6S, 8R)-6-(1-hydroxyethyl)-2-(2-carbamoyloxyethylthio)-penem-3-carboxylate and process for making same
FI871835A (fi) * 1986-04-29 1987-10-30 Ciba Geigy Ag Kristallint hydrat.
GB8915392D0 (en) * 1989-07-05 1989-08-23 Erba Carlo Spa Process for penems

Also Published As

Publication number Publication date
HUT56571A (en) 1991-09-30
DK85490A (da) 1990-06-07
IL91216A0 (en) 1990-03-19
IL91216A (en) 1994-10-21
EP0407478A1 (en) 1991-01-16
HU205934B (en) 1992-07-28
US5302588A (en) 1994-04-12
NZ230196A (en) 1990-09-26
JP2954956B2 (ja) 1999-09-27
HU894594D0 (en) 1991-07-29
RU2074858C1 (ru) 1997-03-10
IE68447B1 (en) 1996-06-26
IE892528L (en) 1990-02-08
DE68918849T2 (de) 1995-02-23
GB8818789D0 (en) 1988-09-07
FI901710A0 (fi) 1990-04-04
DK171235B1 (da) 1996-08-05
AU626576B2 (en) 1992-08-06
FI95575C (fi) 1996-02-26
DE68918849D1 (de) 1994-11-17
JPH03500781A (ja) 1991-02-21
PT91383B (pt) 1995-05-31
GR1002251B (en) 1996-04-23
AU4049089A (en) 1990-03-05
DK85490D0 (da) 1990-04-05
WO1990001484A1 (en) 1990-02-22
EP0407478B1 (en) 1994-10-12
ZA895966B (en) 1990-06-27
ES2015770A6 (es) 1990-09-01
GR890100493A (el) 1990-08-22
FI95575B (fi) 1995-11-15
CA1339422C (en) 1997-09-02
ATE112777T1 (de) 1994-10-15
PT91383A (pt) 1990-03-08

Similar Documents

Publication Publication Date Title
HUT50786A (en) Process for producing new condensed heterocyclic compounds and pharmaceutical compositions containing them as active components
ES2090713T3 (es) Sales organicas de n,n'-diacetil-cistina.
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
CO4440626A1 (es) Amidas terapeuticas
RU95114376A (ru) Нитроэфиры, обладающие фармакологической активностью, и способ их получения
DK0421561T3 (da) 24-homo-vitamin-D-derivater, fremgangsmåder til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt deres anvendelse som lægemiddel
SE9402595L (sv) Förfarande för kristallisation av iopamidol
CA2133885A1 (en) Crystalline inclusion complex of diclofenac with beta-cyclodextrin
KR900701799A (ko) 결정성(5r, 6s)-2-카바모일옥시메틸-6-[(1r)-하이드록시에틸]-2- 페넴-카복실 산 및 이의 약제형
IL97855A0 (en) Bromide containing pharmaceutical compositions for treatment of psoriasis
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
DE3264906D1 (en) Aminoglycoside derivatives, processes for their production, pharmaceutical compositions containing them and such derivatives for use as pharmaceuticals
IT1237529B (it) Composti spiro-indolino-ossazine con caratteristiche fotocromatiche e fotosensibilizzatrici e procedimento per la loro preparazione
ES2105355T3 (es) Procedimiento para la preparacion de 2-aminopropanal opticamente activo.
ES8506749A1 (es) Procedimiento para la produccion de 1-n -(l-3-amino-2-hidroxipropionilo)- o 1-n-(l-4-amino-2-hidroxibutirilo)-2',3'-dideoxikanamicina a
PT937727E (pt) Processo para a producao de cefuroxima azetil cristalina soluvel
AU6797590A (en) Improvements in or relating to organic compounds
BR0010753A (pt) Processo para preparação de massas moldáveis termoplásticas com emprego de soluções de borracha
HUP9801811A2 (hu) Polihidroxi-alkil-aminok koncentrált oldatai és ezek alkalmazása, különösen polihidroxi-alkil-karbonsavamidok előállításához
KR900014372A (ko) 티에닐피페라진 이의 제조방법 및 이를 함유하는 약제
TH14132A (th) สารผสมต้านเนื้องอกและวิธีการรักษา
SU1706174A3 (ru) N-замещенные 5-фталимидонафталин-1-сульфамиды в качестве полупродуктов для получения n-замещенных аминонафталинсульфамидов
TH25496A (th) เกลือของกรดคลาวูลานิก
DE59400178D1 (de) Verfahren zur Herstellung von 2-(1-Cyclohexenyl)ethylamin
TH13044EX (th) สารประกอบทางเภสัชกรรม

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application